Cormorant Asset Management, LP's Form 4 filing
OnKure Therapeutics, Inc. (OKUR) · filed May 14, 2025
- Accession no.
- 0000929638-25-001870
- Filed
- May 14, 2025, 4:36 PM ET
- Trade date
- May 12, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $48.2K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Cormorant Asset Management, LPCIK 0001583977 | 10% Owner |
| Chen BihuaCIK 0001599214 | 10% Owner |
| Cormorant Global Healthcare Master Fund, LPCIK 0001618442 | 10% Owner |
| Cormorant Private Healthcare Fund III LPCIK 0001817320 | 10% Owner |
| Cormorant Private Healthcare Fund IV LPCIK 0001871297 | 10% Owner |
| Cormorant Private Healthcare Fund V LPCIK 0001969296 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 12, 2025 | Class A Common Stock | SSaleDisposed | −24,300 | $1.99 | −$48,235.5 | 1,813,439 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.